To study prognostic factors in patients with sustained ventricular tachycardias (VT) or ventricular fibrillation (VF) complicated by left ventricular dysfunction, we evaluated the predictive value of demographic, clinical, and hemodynamic parameters for cardiac mortality and sudden cardiac death in 85 patients with VT or VF and left ventricular ejection fractio
Sustained ventricular arrhythmias and heart failure are well-recognized complications after acute my...
More than 450000 Americans die suddenly each year from sustained ventricular tachycardia or fibrilla...
Sudden cardiac death (SCD) in patients with ischemic heart disease remains a leading cause of death....
To study prognostic factors in patients with sustained ventricular tachycardias (VT) or ventricular ...
Background: About 20% of patients who develop left ventricular (LV) systolic dysfunction will have i...
Introduction: About 25% of patients who develop left ventricle (LV) systolic dysfunction will have i...
We analyzed the long-term outcome of antiarrhythmic therapy, each of which had been evaluated at ele...
Current guidelines recommend implantation of prophylactic implantable cardioverter-defibrillators (I...
AbstractIn a multicenter study, 390 patients with sustained symptomatic ventricular tachycardia or v...
BACKGROUND: Determining a specific death cause may facilitate individualized therapy in patients wit...
Sudden cardiac deaths account for 350,000 to 380,000 deaths in the United States annually. Implantab...
The use of β-blockers represents a milestone in the treatment of heart failure with reduced ejection...
Background Patients with structural heart disease are prone to ventricular tachycardia (VT) and vent...
Background— Therapies for patients with chronic heart failure caused by left ventricular systolic d...
BACKGROUND: Patients with structural heart disease are prone to ventricular tachycardia (VT) and ven...
Sustained ventricular arrhythmias and heart failure are well-recognized complications after acute my...
More than 450000 Americans die suddenly each year from sustained ventricular tachycardia or fibrilla...
Sudden cardiac death (SCD) in patients with ischemic heart disease remains a leading cause of death....
To study prognostic factors in patients with sustained ventricular tachycardias (VT) or ventricular ...
Background: About 20% of patients who develop left ventricular (LV) systolic dysfunction will have i...
Introduction: About 25% of patients who develop left ventricle (LV) systolic dysfunction will have i...
We analyzed the long-term outcome of antiarrhythmic therapy, each of which had been evaluated at ele...
Current guidelines recommend implantation of prophylactic implantable cardioverter-defibrillators (I...
AbstractIn a multicenter study, 390 patients with sustained symptomatic ventricular tachycardia or v...
BACKGROUND: Determining a specific death cause may facilitate individualized therapy in patients wit...
Sudden cardiac deaths account for 350,000 to 380,000 deaths in the United States annually. Implantab...
The use of β-blockers represents a milestone in the treatment of heart failure with reduced ejection...
Background Patients with structural heart disease are prone to ventricular tachycardia (VT) and vent...
Background— Therapies for patients with chronic heart failure caused by left ventricular systolic d...
BACKGROUND: Patients with structural heart disease are prone to ventricular tachycardia (VT) and ven...
Sustained ventricular arrhythmias and heart failure are well-recognized complications after acute my...
More than 450000 Americans die suddenly each year from sustained ventricular tachycardia or fibrilla...
Sudden cardiac death (SCD) in patients with ischemic heart disease remains a leading cause of death....